Salzmann Peter
Immunovant, Inc. · Chief Executive Officer
Salzmann Peter is listed in filings as Chief Executive Officer at Immunovant, Inc.. This profile follows SEC Form 4 activity through Apr 17, 2025, including sale activity. Recent filings connect the profile to Immunovant, Inc. (IMVT). The current snapshot covers public activity from Jul 10, 2024 to Apr 17, 2025. Reported amounts are shown as $129.6K to $242.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $124k8.3k shares | SellApr 16, 2025 | $14.89 | $38.96 |